Medical regulators approve a gene therapy that aims to cure sickle cell disease and beta thalassemia.

The Crick, the UK’s largest discovery biomedical research lab, has offered to support the Government’s efforts to tackle the spread of COVID-19.

DeepMind will establish a research laboratory at the Crick, applying machine learning and artificial intelligence techniques to advance understanding of biology, including protein design and genomi...

The Francis Crick Institute has repurposed its laboratory facilities to become a COVID-19 testing facility, to help combat the spread of infection and allow key workers to perform lifesaving duties...

UCLH and the Francis Crick Institute have formed a partnership to deliver a new large-scale COVID-19 vaccination centre at the institute.

A joint letter from the Directors of the Francis Crick Institute, the European Molecular Biology Laboratory and the Wellcome Sanger Institute.

Researchers at the Crick have found that CRISPR-Cas9 genome editing can lead to unintended mutations at the targeted section of DNA. The work, which looked at samples from early human embryos,...

Crick group leader Charles Swanton has been awarded the Memorial Sloan Kettering Cancer Center’s 2021 Paul Marks Prize for Cancer Research.

Applications are now open until 5 October 2023.

Brian Cox and Robin Ince look at the amazing story of the discovery of King Richard III.

Charlie Swanton, Deputy Clinical Director at the Crick, has been awarded the 2024 Jeantet-Collen Prize for Translational Medicine for his research in cancer genetics and evolution, leading to...

The Crick and the European Molecular Biology Laboratory (EMBL) have signed a collaboration agreement to strengthen pan-European scientific cooperation.

Crick group leaders Caetano Reis e Sousa and James Briscoe have been elected as Fellows of the Royal Society in recognition of their outstanding contributions to science.

Crick PhD students Kevin and Nikhil are finding out what happens to our immune system when it's exposed to SARS-CoV-2.

Crick group leader Katharina Schmack has been awarded over £5million from Wellcome to study the effects of antipsychotic drugs on the immune system. 

A new drive-through coronavirus swabbing facility for NHS staff has opened in central London at the British Library, in partnership with University College London Hospitals NHS Foundation Trust and...

Two Crick group leaders, Erik Sahai and James Turner, have been elected as fellows of the prestigious Academy of Medical Sciences for their contributions to cancer research and developmental biology. 

Researchers have come up with an inexpensive, automated way to image biological samples, using the children’s toy, LEGO.

Coronavirus is bringing rapid and dramatic shifts in medical research

Cancer Research UK-funded scientists at the Francis Crick Institute and UCL have revealed how air pollution can cause lung cancer in people who have never smoked. 

After delivering more than 80,000 COVID-19 vaccines, the vaccination centre at the Francis Crick Institute closes its doors today with the last vaccination taking place at 7pm.

DR PAUL NURSE: Scientists, such as those in Oxford, have worked at breakneck speed to create Covid-19 vaccines in record time despite the scepticism created by populist politicians.

Pontus Skoglund, Group Leader of the Ancient Genomics Laboratory at the Francis Crick Institute, has been awarded a €2m Consolidator Grant from the European Research Council (ERC) to study dog...

Investigação liderada por cientista português, publicada em 2015 na revista Cell, analisa a combinação da aspirina a uma terapia imunitária para o cancro e vence a primeira edição do Prémio Bial em...

We recently welcomed Francesca Ester Morreale to the Crick. Ester joins us from the Research Institute of Molecular Pathology in Vienna. Her team will be looking at protein degradation in bacteria,...

Researchers at the Crick, King’s College London and Guy's and St Thomas' NHS Foundation Trust have conducted a highly detailed analysis of the composition of immune cells in the blood of patients...

Researchers at the Crick have validated a method to test for SARS-CoV-2. The team have shared their protocols for using this promising method and how to report results to health authorities. 

A collection of TRACERx papers published in Nature journals have transformed our understanding of how lung cancer evolves over time.

Crick Group Leader James Turner has been elected as a Fellow of the Royal Society in recognition of his outstanding contribution to science.

Applications are now open for the Spring round of 2024 PhD recruitment! The deadline for applications is 12:00PM, midday (GMT) 19 March 2024.

Scientists at the Crick, Great Ormond Street Hospital and UCL Great Ormond Street Institute of Child Health have grown human intestinal grafts using stem cells from patient tissue that could one day...

Researchers at the Francis Crick Institute have found that cellular structures called stress granules perform an essential protective function in support of the immune response against infections...

Crick group leaders Ben Schumann and Pontus Skoglund have been selected as two of this year’s new EMBO Young Investigators.

Paola Bonfanti and Charlie Swanton have each been awarded €2.5m in prestigious Advanced Grants from the European Research Council (ERC) for pioneering research projects in the immune system and...

Kevin Ng, Postdoctoral Research Assistant at the Crick, has been awarded a Schmidt Science Fellowship to speed up the process of selecting promising vaccine candidates. 

Until a vaccine is found, testing, tracing and isolation is the only way to stop the further spread of coronavirus in Britain, says Rupert Beale, of the Francis Crick Institute

Researchers studying the spread of SARS-CoV-2 among healthcare workers have found high levels of asymptomatic infections during the peak of the pandemic in London.

The Vallee Foundation has named Crick group leader, Pontus Skoglund, as one of its Vallee Award Scholars for 2020.  

Applications are now open until 5 October 2023.